Jin, Jing
Fan, Xiucong
Dong, Xiaohui
Zhai, Xiaobo
Ma, Yabin
Tang, Jing
Funding for this research was provided by:
Shanghai "Rising Stars of Medical Talent" Youth Development Program (076478684Q/2022-00033)
project of China Pharmaceutical Association (CMEI2022KPYJ00545)
The Natural Science Foundation of China (81603097)
Key Specialties Foundation of Clinical Pharmacy of Shanghai Municipal Health Commission in China (SWLCYXZX-2018-001)
Research on the Epidemiology of Severe Drug-induced Diseases of the Chinese Society of Toxicology (CST2019CT304)
project of Shanghai Hospital Association (YS2021003)
project of Shanghai Higher Education Association (Z2-04)
Article History
Received: 24 June 2022
Accepted: 8 October 2022
First Online: 3 November 2022
Declarations
:
: This study was conducted in accordance with the ethical standards of the Helsinki Declaration, and the Ethics Committee of the Obstetrics and Gynecology Hospital affiliated with Fudan University approved this study design. The approval number was 2021-115. This was a retrospective study with an informed consent exemption. Patient consent was not needed.
: The authors confirm that the work described has not been published before. We agree to publication in the European Journal of Medical Research.
: The authors declare no conflicts of interest.